6
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Isolation of Serologically Active Hla-A,B,C and Dr Antigens as Monitored by a Fixed Cell Radioimmunoassay

, &
Pages 625-636 | Published online: 07 Jul 2009
 

Abstract

Procedures for isolation of antigenically active preparations of human HLA antigens were monitored using a sensitive and quantitative radioimmunoassay for HLA-A,B,C or HLA-DR antigens. These assays involve binding of radiolabeled monoclonal antibodies to appropriate target cells and inhibition of this binding by solubilized antigen preparations. Fixation of the target cells with glutaraldehyde allows quantitation of inhibitors in high concentrations of nonionic detergents. Using this assay, it was possible to examine quantitatively the relative merits of several alternative procedures for isolating both class I and class II antigens. For example, chromatography of cell lysates on columns of Ricinus communis agglutinin gave high recoveries of DR antigens purified from the majority of cell proteins. When Lens culinaris hemagglutinin was used for separation of cell lysates approximately 90% of the A,B,C antigens but only 32% of the DR antigens bound the column and were eluted by α-methyl-mannoside. Immunoadsorbent columns were then used to recover antigenically active molecules suitable for structural or functional studies from these enriched fractions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.